Number of Clinical Trials 2014

Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.

122 data points••Global Coverage•Number of clinical trials | ClinicalTrials.gov via Our World in Data•

Newer data is available: Number of Clinical Trials by country 2024 →

Highest
United States
5,193
Lowest
Papua New Guinea
1
Median country
6.5
Countries with data
122

Where does your country rank? Pick it to see its position.

Related Health statistics

More ↓

Interactive Map

Loading interactive map...

Complete Data Rankings

Rank
Actions
1
United States flag
United States
5,193
2
France flag
France
630
3
Germany flag
Germany
558
4
Canada flag
Canada
527
5
United Kingdom flag
United Kingdom
477
6
South Korea flag
South Korea
464
7
China flag
China
404
8
Denmark flag
Denmark
256
9
Italy flag
Italy
256
10
Spain flag
Spain
251
11
Japan flag
Japan
249
12
Netherlands flag
Netherlands
232
13
Belgium flag
Belgium
198
14
Brazil flag
Brazil
191
15
Switzerland flag
Switzerland
141
16
Sweden flag
Sweden
134
17
Taiwan flag
Taiwan
115
18
Israel flag
Israel
112
19
India flag
India
109
20
Norway flag
Norway
104
21
Turkey flag
Turkey
97
22
Australia flag
Australia
97
23
Austria flag
Austria
79
24
Egypt flag
Egypt
76
25
Thailand flag
Thailand
68
26
Mexico flag
Mexico
56
27
Poland flag
Poland
56
28
Greece flag
Greece
54
29
Finland flag
Finland
53
30
Russia flag
Russia
52
31
Singapore flag
Singapore
50
32
Iran flag
Iran
39
33
South Africa flag
South Africa
32
34
Czech Republic flag
Czech Republic
28
35
Kenya flag
Kenya
28
36
Argentina flag
Argentina
24
37
Malaysia flag
Malaysia
23
38
China, Hong Kong SAR flag
China, Hong Kong SAR
21
39
Indonesia flag
Indonesia
19
40
Slovenia flag
Slovenia
19
41
Uganda flag
Uganda
18
42
Bangladesh flag
Bangladesh
18
43
Ireland flag
Ireland
17
44
Pakistan flag
Pakistan
17
45
Portugal flag
Portugal
17
46
Hungary flag
Hungary
16
47
Saudi Arabia flag
Saudi Arabia
15
48
Bulgaria flag
Bulgaria
13
49
Colombia flag
Colombia
13
50
New Zealand flag
New Zealand
13
51
Tunisia flag
Tunisia
12
52
Vietnam flag
Vietnam
12
53
Philippines flag
Philippines
12
54
Chile flag
Chile
11
55
Romania flag
Romania
11
56
Zambia flag
Zambia
10
57
Tanzania flag
Tanzania
9
58
Malawi flag
Malawi
9
59
Burkina Faso flag
Burkina Faso
8
60
Jordan flag
Jordan
8
61
Lebanon flag
Lebanon
7
62
Croatia flag
Croatia
6
63
Ethiopia flag
Ethiopia
6
64
Rwanda flag
Rwanda
6
65
Ukraine flag
Ukraine
5
66
Afghanistan flag
Afghanistan
4
67
Cambodia flag
Cambodia
4
68
Estonia flag
Estonia
4
69
Ghana flag
Ghana
4
70
Latvia flag
Latvia
4
71
Mali flag
Mali
4
72
Panama flag
Panama
4
73
Peru flag
Peru
4
74
Qatar flag
Qatar
4
75
Serbia flag
Serbia
4
76
Uruguay flag
Uruguay
3
77
Belarus flag
Belarus
3
78
Botswana flag
Botswana
3
79
Dominican Republic flag
Dominican Republic
3
80
Lesotho flag
Lesotho
3
81
Nepal flag
Nepal
3
82
Niger flag
Niger
3
83
Puerto Rico flag
Puerto Rico
3
84
Senegal flag
Senegal
3
85
Bosnia and Herzegovina flag
Bosnia and Herzegovina
2
86
Cameroon flag
Cameroon
2
87
Cyprus flag
Cyprus
2
88
Ecuador flag
Ecuador
2
89
Georgia flag
Georgia
2
90
Guinea-Bissau flag
Guinea-Bissau
2
91
Iceland flag
Iceland
2
92
Kazakhstan flag
Kazakhstan
2
93
Lithuania flag
Lithuania
2
94
Martinique flag
Martinique
2
95
Republic of Moldova flag
Republic of Moldova
2
96
Morocco flag
Morocco
2
97
Myanmar flag
Myanmar
2
98
Nigeria flag
Nigeria
2
99
Paraguay flag
Paraguay
2
100
Sierra Leone flag
Sierra Leone
2
101
Slovakia flag
Slovakia
2
102
United Arab Emirates flag
United Arab Emirates
1
103
Venezuela flag
Venezuela
1
104
Zimbabwe flag
Zimbabwe
1
105
Algeria flag
Algeria
1
106
Bahrain flag
Bahrain
1
107
Benin flag
Benin
1
108
Congo flag
Congo
1
109
Costa Rica flag
Costa Rica
1
110
Cuba flag
Cuba
1
111
Gambia flag
Gambia
1
112
Guyana flag
Guyana
1
113
Iraq flag
Iraq
1
114
Jamaica flag
Jamaica
1
115
Kyrgyzstan flag
Kyrgyzstan
1
116
Luxembourg flag
Luxembourg
1
117
Mauritius flag
Mauritius
1
118
Mongolia flag
Mongolia
1
119
Montenegro flag
Montenegro
1
120
North Macedonia flag
North Macedonia
1
121
State of Palestine flag
State of Palestine
1
122
Papua New Guinea flag
Papua New Guinea
1

↑Top 10 Countries

  1. #1United States flagUnited States
  2. #2France flagFrance
  3. #3Germany flagGermany
  4. #4Canada flagCanada
  5. #5United Kingdom flagUnited Kingdom
  6. #6South Korea flagSouth Korea
  7. #7China flagChina
  8. #8Denmark flagDenmark
  9. #9Italy flagItaly
  10. #10Spain flagSpain

Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.

↓Bottom 10 Countries

  1. #122Papua New Guinea flagPapua New Guinea
  2. #121State of Palestine flagState of Palestine
  3. #120North Macedonia flagNorth Macedonia
  4. #119Montenegro flagMontenegro
  5. #118Mongolia flagMongolia
  6. #117Mauritius flagMauritius
  7. #116Luxembourg flagLuxembourg
  8. #115Kyrgyzstan flagKyrgyzstan
  9. #114Jamaica flagJamaica
  10. #113Iraq flagIraq

Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.

Insights by country

1

Singapore

In 2014, Singapore ranked #31 globally with a total of 50 clinical trials. This figure is notably higher than that of many Southeast Asian neighbors, reflecting Singapore's status as a regional hub for biomedical research. The country's robust healthcare infrastructure, government support for innovation, and strategic investments in research and development significantly contribute to its clinical trial activity.

2

Canada

In 2014, Canada ranked #4 globally with a total of 527 clinical trials. This figure highlights Canada's robust research infrastructure, significantly higher than the global average. Key drivers include a strong emphasis on healthcare innovation, a well-established regulatory framework, and partnerships between academic institutions and the pharmaceutical industry.

3

Jordan

In 2014, Jordan ranked #59 globally with a total of 8 clinical trials. This figure is notably lower than the global average, reflecting the challenges faced by the country in attracting significant research investments compared to leading nations. Key drivers of this statistic include Jordan's limited healthcare funding and a smaller population base, which can hinder the scale and scope of clinical research initiatives.

4

Czech Republic

In 2014, the Czech Republic ranked #34 globally with a total of 28 clinical trials. This figure is relatively modest compared to leading countries in clinical research, such as the United States, which hosts thousands of trials annually. The Czech Republic benefits from a well-educated healthcare workforce and a supportive regulatory environment, which facilitates clinical research while attracting international pharmaceutical companies to conduct trials within its borders.

5

Venezuela

In 2014, Venezuela ranked #122 globally with a total of 1 clinical trial. This figure is notably low compared to other countries, reflecting the country's position as the bottom-ranked nation in this category. Contributing factors include ongoing economic instability and a challenging political environment, which hinder investment in healthcare and research initiatives.

6

Egypt

In 2014, Egypt ranked #24 globally with a total of 76 clinical trials. This figure is notable when compared to other countries in the region, indicating a robust clinical research environment. The growth in clinical trials in Egypt can be attributed to its strategic geographic location, which facilitates international collaboration, as well as a growing population that presents a diverse pool for research studies.

7

Nepal

Nepal ranked #80 out of 122 countries for the Number of Clinical Trials in 2014, with a total of 3 trials conducted. This figure is significantly lower than many neighboring countries, which often have more robust clinical research infrastructures. Contributing factors include limited funding for healthcare initiatives, a smaller population base for trial recruitment, and regulatory challenges that hinder the growth of clinical research in the country.

8

State of Palestine

In 2014, the State of Palestine ranked #109 globally with a total of 1 clinical trial. This is significantly lower than many neighboring countries, reflecting limited resources and infrastructure for clinical research. The primary drivers behind this statistic include ongoing political instability and restrictions on movement, which hinder collaboration with international research entities and access to necessary funding.

9

Ukraine

In 2014, Ukraine ranked #65 globally with a total of 5 clinical trials. This figure is notably lower than many of its Eastern European neighbors, reflecting challenges in the region's healthcare infrastructure and regulatory environment. Factors such as ongoing political instability and limited investment in medical research have hindered the growth of clinical trials in Ukraine, impacting its ability to attract international pharmaceutical companies.

10

Gambia

In 2014, Gambia ranked #108 globally with a total of 1 clinical trial. This figure is notably low compared to many countries in the region, which often have multiple trials underway to address local health challenges. The limited number of clinical trials in Gambia can be attributed to factors such as a small population, underfunded healthcare infrastructure, and a lack of investment in research and development initiatives.

Analysis & Context

In 2014, the United States led the world in the Number of Clinical Trials with a total of 5193, while globally, the number ranged from a minimum of 1 to a maximum of 5193. The median number of clinical trials conducted worldwide was 7, providing a clear indication of the disparity in medical research activities across different countries.

Concentration of Clinical Trials in Developed Nations

The concentration of clinical trials in 2014 was heavily skewed towards developed nations, with the United States far outpacing other countries by a substantial margin. Following the U.S., France and Germany had 630 and 558 trials respectively. This trend can be attributed to several factors, including robust healthcare infrastructure, significant investment in biomedical research, and the presence of major pharmaceutical companies. Countries like Canada and the United Kingdom also featured prominently, with 527 and 477 trials, underscoring their capacity for medical innovation and research.

Limited Activity in Developing Regions

In stark contrast, several developing countries reported only 1 clinical trial each, including Bahrain, Congo, and Benin. The limited activity in these regions can often be linked to constrained economic resources, fewer research facilities, and a lack of regulatory frameworks conducive to supporting extensive clinical research. Moreover, geopolitical instability in some areas further hinders the establishment and execution of clinical trials.

Year-over-Year Changes and Emerging Trends

The data from 2014 also highlights significant year-over-year changes in clinical trial numbers. The United States saw an increase of 300 trials, a growth of 6.1%, reflecting ongoing advancements and investments in medical research. Similarly, the United Kingdom and China experienced notable increases of 94 and 70 trials respectively, indicating an expanding focus on healthcare innovation. On the other hand, some countries experienced declines; for instance, Taiwan saw a reduction of 39 trials, a decrease of 25.3%, potentially due to shifts in research priorities or economic constraints.

Implications for Global Health Research

The distribution of clinical trials in 2014 underscores the critical role of economic and infrastructural capabilities in facilitating medical research. Developed countries, with their established research ecosystems, continue to lead in clinical trials, driving innovation and new treatments. However, the limited participation of developing nations highlights the need for increased international collaboration and support to bridge the gap in global health research. By fostering partnerships and investing in capacity building, the global community can enhance the diversity and applicability of clinical research, ultimately benefiting a broader swath of the world's population.

Frequently Asked Questions About Number of Clinical Trials in 2014

Which country had the highest number of clinical trials in 2014?

The United States had the highest number of clinical trials in 2014, with a total of 5,193.

What was the average number of clinical trials conducted by countries in 2014?

The average number of clinical trials conducted by countries in 2014 was 98.22.

Which country had the lowest number of clinical trials in 2014?

Bahrain had the lowest number of clinical trials in 2014, with just 1 trial.

What was the median number of clinical trials conducted by countries in 2014?

The median number of clinical trials conducted by countries in 2014 was 6.5.

How many countries conducted only one clinical trial in 2014?

There were 10 countries that conducted only one clinical trial in 2014.

Which countries were in the top 10 for the number of clinical trials in 2014?

The top 10 countries for the number of clinical trials in 2014 were the United States, France, Germany, Canada, United Kingdom, South Korea, China, Denmark, Italy, and Spain.

Data Source

Number of clinical trials | ClinicalTrials.gov via Our World in Data

Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".

Visit Data Source

Cite this page

Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2014. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2014

The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.

›Embed this ranking on your site

Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.

Preview

Historical Data by Year

Explore Number of Clinical Trials data across different years. Compare trends and see how statistics have changed over time.